Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions

Neuroblastoma

Interventions

RADIATION

External beam radiotherapy

RADIATION

proton beam RT

Trial Locations (1)

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02245997 - Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma | Biotech Hunter | Biotech Hunter